We are proud to support #CEPAS2026 — the Congress of the European Paediatric Academic Societies — taking place 28–31 October 2026 in Lyon, France.

CEPAS is the brand-new biennial meeting of the European Academy of Paediatrics (@EAPaediatrics) and the European Society for Paediatric Research (@ESPR_ESN).

Abstract submission closes on 1 April 2026, 23:59 CEST

🔗 https://www.cepas.org/

#CEPAS2026 #paediatric #paediatricresearch

📢 Our May newsletter is now online! This month we're focusing on the value of #PPPs to address #HealthChallenges. Discover:
✅ Draft texts for call 11
✅ Info webinars on call 11
✅ New project INTERCEPT
✅ Project results for #ClinicalTrials, #PaediatricResearch and #VaccineResearch
👉 https://europa.eu/!6mvTjP #IHITransformingHealth #HealthResearch
IHI Newsletter | Spotlight on the value of PPPs

IHI Innovative Health Initiative
🚸 Children deserve to have medicines, medical devices and diagnostics that are adapted to their needs.
✒️ Writing in Frontiers in Medicine, IHI's Nathalie Seigneuret outlines how our projects are advancing #PaediatricResearch.
👉 Read more: europa.eu/!TTkHhJ
#IHITransformingHealth #HorizonEU

Guardians and research staff experiences and views about the consent process in hospital-based paediatric research studies in urban Malawi: A qualitative study

#ResearchEthics #InformedConsent #PaediatricResearch

https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-022-00865-x

Guardians and research staff experiences and views about the consent process in hospital-based paediatric research studies in urban Malawi: A qualitative study - BMC Medical Ethics

Background Obtaining consent has become a standard way of respecting the patient’s rights and autonomy in clinical research. Ethical guidelines recommend that the child’s parent/s or authorised legal guardian provides informed consent for their child’s participation. However, obtaining informed consent in paediatric research is challenging. Parents become vulnerable because of stress related to their child’s illness. Understanding the views held by guardians and researchers about the consent process in Malawi, where there are limitations in health care access and research literacy will assist in developing appropriate consent guidelines. Methods We conducted 20 in-depth interviews with guardians of children and research staff who had participated in paediatric clinical trial and observational studies in acute and non-acute settings in the Southern Region of Malawi. Interviews were audio-recorded, transcribed verbatim, and thematically analysed. Interviews were compared across studies and settings to identify differences and similarities in participants’ views about informed consent processes. Data analysis was facilitated by NVIVO 11 software. Results All participants across study types and settings reported that they associated participating in research with therapeutic benefits. Substantial differences were noted in the decision-making process across study settings. Guardians from acute studies felt that the role of their spouses was neglected during consenting, while staff reported that they had problems obtaining consent from guardians when their partners were not present. Across all study types and settings, research staff reported that they emphasised the benefits more than the risks of the study to participants, due to pressure to recruit. Participants from non-acute settings were more likely to recall information shared during the consent process than participants in the acute setting. Conclusion The health care context, culture and research process influenced participants’ understanding of study information across study types and settings. We advise research managers or principal investigators to define minimum requirements that would not compromise the consent process and conduct study specific training for staff. The use of one size fits all consent process may not be ideal. More guidance is needed on how these differences can be incorporated during the consent process to improve understanding and delivery of consent. Trial registration Not applicable.

BioMed Central

Go go, the first-ever Brussels-based #TeamRynkeby! In July, they & 2,200 others will cycle 1,100 km to Paris. Final destination: To raise money to fight serious children’s diseases. Enjoy the ride! http://team-rynkeby.be #tourdeparis2022 #paediatricresearch Photo Emma Laycock

🐦🔗: https://nitter.eu/vestager/status/1546075051149168640

Team Rynkeby